General Notices

• Notice of Special Topics of Interest for CDER for PAR-23-072 "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)"
  (NOT-FD-23-007)
  Food and Drug Administration
  

• Notice of Technical Assistance Webinar for RFA-HL-24-003 & RFA-HL-24-004 "Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24) & (R25 Clinical Trial Not Allowed)"
  (NOT-HL-23-075)
  National Heart, Lung, and Blood Institute
  

Notice of Changes to Funding Opportunities

• Notice of Change to Key Dates to RFA-AG-24-003, Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-AG-23-003)
  National Institute on Aging
  

• Notice of NCIs Participation in PAR-23-112, Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
  (NOT-CA-23-043)
  National Cancer Institute
  

• Notice of Change to Key Dates for RFA-NS-23-012 "Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)"
  (NOT-NS-23-073)
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
  (NOT-DK-23-012)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement to Reissue RFA-OD-21-002, the Tobacco Regulatory Science (R01 Clinical Trial Optional)
  (NOT-OD-23-081)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  

Requests for Proposal

• NIA Caenorhabditis Interventions Testing Program (CITP) Announces Annual Call for Compounds to Test for Lifespan Extension in Caenorhabditis
  (NOT-AG-23-001)
  National Institute on Aging
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes
  (NOT-AG-23-004)
  National Institute on Aging
  

• Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
  (NOT-MD-23-002)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
  (NOT-MD-23-003)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Eye Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS)
  (NOT-NS-23-062)
  National Institute of Neurological Disorders and Stroke
  

Funding Opportunities

• Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  (PAR-23-035)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): March 21, 2023
  
  

• Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
  (RFA-AI-22-076)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 09, 2023
  
  

• Consortium for Food Allergy Research: Leadership Center (UM1 Clinical Trial Required)
  (RFA-AI-22-077)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 09, 2023
  
  

• Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
  (RFA-DA-24-037)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 15, 2024
  
  

• Limited Competition for the Continuation of the Rare and Atypical Diabetes NeTwork (RADIANT) Specialized Study Centers (U54 - Clinical Trial Not Allowed)
  (RFA-DK-22-511)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): June 07, 2023
  
  

• Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-OD-23-004)
  Office of Research on Women's Health
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): January 31, 2024